News
Present at Creation of Nobel-Winning 'Checkpoint Inhibitor' Therapies, Immunologist Looks to the Future
Twenty-two years ago, the possibility of using immunotherapy to treat cancer was just being demonstrated in mice. Now the therapies are showing dramatic success in thousands of human patients and have just been acknowledged with a Nobel Prize. Researchers at UC San Francisco and elsewhere are
UCSF Health and John Muir Health to Build East Bay Cancer Network
UCSF Health and John Muir Health have signed a letter of intent to develop a cancer network designed to improve prevention, diagnosis and treatment for patients throughout the East Bay. The joint East Bay Cancer Network will include development of distinguished disease-specific treatment
UCSF Receives $20 Million to Study New Tobacco Products
UC San Francisco has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products, including e-cigarettes and heated tobacco products (HTPs), which heat tobacco without
Q&A with Mike Rabow, MD, Director of the HDFCCC Symptom Management Service
In the 13 years since Mike Rabow, MD, established the Symptom Management Service at the UCSF Helen Diller Family Comprehensive Cancer Center, with the support of Peter Carroll, MD, Gerri Shields, and the Mount Zion Health Fund, the specialty palliative care program has grown into one of largest in
'ImmunoX' Initiative a Radical Collaboration Across UCSF
UC San Francisco is launching the Bakar ImmunoX Initiative, an innovative research program that will promote collaborative, cutting-edge research and data sharing to catalyze discoveries about the central role of the immune system in human health and harness its power to treat a wide range of
UCSF Researchers Identify Unique Genetic Alterations in Brain Tumors Occurring After Radiation
For many common childhood cancers, radiation therapy can be an effective, even curative, treatment. However, long-term survivors are at risk for developing new, or secondary, cancers as a consequence of radiation, sometimes decades later. Children with cancers like medulloblastoma and
Scientists Map Interactions between Head and Neck Cancer and HPV Virus
Human papillomavirus (HPV) is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils. Although vaccines that protect against HPV